EVOCLIN Drug Patent Profile

Which patents cover Evoclin, and what generic alternatives are available?

Evoclin is a drug marketed by Norvium Bioscience and is included in one NDA. There are two patents protecting this drug.

This drug has thirty patent family members in fifteen countries.

The generic ingredient in EVOCLIN is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Evoclin

A generic version of EVOCLIN was approved as clindamycin phosphate by ALMAJECT on July 24^th, 1987.

Summary for EVOCLIN

International Patents:	30
US Patents:	2
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	57
Drug Prices:	Drug price information for EVOCLIN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for EVOCLIN
What excipients (inactive ingredients) are in EVOCLIN?	EVOCLIN excipients list
DailyMed Link:	EVOCLIN at DailyMed

See drug prices for EVOCLIN

US Patents and Regulatory Information for EVOCLIN

EVOCLIN is protected by two US patents.

Patents protecting EVOCLIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Norvium Bioscience	EVOCLIN	clindamycin phosphate	AEROSOL, FOAM;TOPICAL	050801-001	Oct 22, 2004		DISCN	Yes	No			Y
Norvium Bioscience	EVOCLIN	clindamycin phosphate	AEROSOL, FOAM;TOPICAL	050801-001	Oct 22, 2004		DISCN	Yes	No			Y

Expired US Patents for EVOCLIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Norvium Bioscience	EVOCLIN	clindamycin phosphate	AEROSOL, FOAM;TOPICAL	050801-001	Oct 22, 2004
Norvium Bioscience	EVOCLIN	clindamycin phosphate	AEROSOL, FOAM;TOPICAL	050801-001	Oct 22, 2004

International Patents for EVOCLIN

See the table below for patents covering EVOCLIN around the world.

Country	Patent Number	Title	Estimated Expiration
Norway	339620
Eurasian Patent Organization	014372	ПЕНА НА ОСНОВЕ ФОСФАТА КЛИНДАМИЦИНА (CLINDAMYCIN PHOSPHATE FOAM)
Spain	2637956
World Intellectual Property Organization (WIPO)	2004064833
Eurasian Patent Organization	009031	ПЕНА НА ОСНОВЕ ФОСФАТА КЛИНДАМИЦИНА (CLINDAMYCIN PHOSPHATE BASED FOAM)
Eurasian Patent Organization	200701259	ПЕНА НА ОСНОВЕ ФОСФАТА КЛИНДАМИЦИНА

Supplementary Protection Certificates for EVOCLIN

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	C300617	Netherlands		PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992	122013000081	Germany		PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992	2013C/060	Belgium		PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
1304992	2013/044	Ireland		PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992	CR 2013 00053	Denmark		PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1304992	SPC/GB13/061	United Kingdom		PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624